Skip to main content

Epicentre licenses Reagents to DuPont

NEW YORK, April 19 (GenomeWeb News) - DuPont has taken a license from Epicentre Biotechnologies to use its EZ-Tn5 and HyperMu transposon tools, Epicentre said today.

 

Epicentre develops, manufactures, and sells enzyme systems for life science research. The company said that DuPont will use the reagents to create new biocatalysts.

 

Financial details of the agreement were not released.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.